- US economic uncertainty to spark boom in UK real estate investing
- East Africa’s Real Estate Market Primed for Those Who Know It Best
- AVCA’S Fifth VC Summit Spotlights: Resilience, Scale and Bankability
- Commodities Weekly - Framing tariff-induced stagflation risks
- African Private Capital Fundraising Doubles to $4bn in 2024
Big Pharma Looks Beyond Covid With AstraZeneca Eyeing Gilead
NEW YORK (Capital Markets in Africa) — Two drugmakers behind the industry’s most prominent responses to the Covid-19 pandemic are looking into the possibility of a combined future as economies emerge from lockdowns. AstraZeneca Plc, co-developer of one of the fastest-moving experimental coronavirus vaccines, has made a preliminary approach to Gilead Sciences Inc., maker of the only U.S.-approved treatment, according to people familiar with the matter. If they decided to pursue a merger, it would be…
Read More